Abstract
Graves' disease (GD) is among the most prevalent organ-specific diseases and is one of the most common causes of hyperthyroidism in regions with normal iodine supply. Current therapeutic strategies for the treatment of patients with GD include antithyroid drugs (ATD), thyroid ablation with radioiodine and surgery, which of them is associated with certain risks of complications. The main task of the doctor is to choose the most optimal method to achieve stable remission. In this regard, much attention is paid to the study of predictors of remission, especially after antithyroid drug treatment due to their widespread use as initial therapy. This article is devoted to the consideration of prognostic factors for Graves' disease remission after antithyroid drug treatment.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
